Log in to save to my catalogue

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from pros...

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from pros...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d83e9cf0b5244fd6a2439370f8fc6cb4

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy

About this item

Full title

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

The Journal of Pathology: Clinical Research, 2022-09, Vol.8 (5), p.481-491

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Current biomarkers are inadequate prognostic predictors in localized prostate cancer making treatment decision‐making challenging. Previously, we observed that the combination of more variable telomere length among prostate cancer cells and shorter telomere length in prostate cancer‐associated stromal cells – the telomere biomarker – is strongly as...

Alternative Titles

Full title

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d83e9cf0b5244fd6a2439370f8fc6cb4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d83e9cf0b5244fd6a2439370f8fc6cb4

Other Identifiers

ISSN

2056-4538

E-ISSN

2056-4538

DOI

10.1002/cjp2.288

How to access this item